Novozymes A/S Stock Forecast, Price & News

-0.10 (-0.13 %)
(As of 07/27/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
Volume5,415 shs
Average Volume11,702 shs
Market Capitalization$17.29 billion
P/E Ratio46.77
Dividend Yield0.74%
30 days | 90 days | 365 days | Advanced Chart
Receive NVZMY News and Ratings via Email

Sign-up to receive the latest news and ratings for Novozymes A/S and its competitors with MarketBeat's FREE daily newsletter.

Novozymes A/S logo

About Novozymes A/S

Novozymes A/S produces and sells industrial enzymes and microorganisms in Europe, the Middle East, Africa, North America, the Asia Pacific, and Latin America. The company offers agriculture solutions, including crop production, and animal health and nutrition solutions; liquefaction, saccharifaction, fermentation, cellulosic hydrolysis, and process enhancement solutions for bioenergy; baking, beverages, dairy, starch, and protein ingredients for the food and beverage industry; and laundry, dishwashing, and professional cleaning solutions for the household care industry. It also provides wastewater solutions, such as additives, biogas production, industrial bio cleaning, compound removal, odor control, and system start-up solutions; and textile solutions comprising denim abrasion and finishing, biopreparation, biopolishing bleach clean-up, and desizing solutions. In addition, the company offers forest products that include bleach boosting, deinking, fiber modification, effluent control, pitch and stickies control, and starch modification products; and leather solutions, which comprise biopreparation, degreasing, and re-bating. Further, it provides pharmaceutical solutions, including lipases, immobilized lipases, and proteases for biocatalysis; and rTrypsin for cell culture. Novozymes A/S has collaboration with FMC Corporation to co-develop enzyme solutions. The company is based in Bagsvaerd, Denmark.


See More Headlines

Industry, Sector and Symbol

Sales & Book Value





Social Links


Overall MarketRank

0.98 out of 5 stars

Basic Materials Sector

446th out of 920 stocks

Biological Products, Except Diagnostic Industry

169th out of 213 stocks

Analyst Opinion: 0.0Community Rank: 2.6Dividend Strength: 1.7Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

Novozymes A/S (OTCMKTS:NVZMY) Frequently Asked Questions

Is Novozymes A/S a buy right now?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Novozymes A/S in the last year. There are currently 2 sell ratings, 4 hold ratings and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" Novozymes A/S stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in NVZMY, but not buy additional shares or sell existing shares.
View analyst ratings for Novozymes A/S
or view top-rated stocks.

What stocks does MarketBeat like better than Novozymes A/S?

Wall Street analysts have given Novozymes A/S a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Novozymes A/S wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Novozymes A/S?

Novozymes A/S saw a increase in short interest in the month of July. As of July 15th, there was short interest totaling 3,900 shares, an increase of 44.4% from the June 30th total of 2,700 shares. Based on an average trading volume of 11,400 shares, the short-interest ratio is presently 0.3 days.
View Novozymes A/S's Short Interest

When is Novozymes A/S's next earnings date?

Novozymes A/S is scheduled to release its next quarterly earnings announcement on Tuesday, August 10th 2021.
View our earnings forecast for Novozymes A/S

How were Novozymes A/S's earnings last quarter?

Novozymes A/S (OTCMKTS:NVZMY) posted its earnings results on Wednesday, April, 29th. The biotechnology company reported $0.42 earnings per share for the quarter, meeting the Zacks' consensus estimate of $0.42. The biotechnology company had revenue of $558.75 million for the quarter. Novozymes A/S had a net margin of 20.72% and a trailing twelve-month return on equity of 26.92%.
View Novozymes A/S's earnings history

How has Novozymes A/S's stock been impacted by COVID-19 (Coronavirus)?

Novozymes A/S's stock was trading at $45.0314 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, NVZMY shares have increased by 68.3% and is now trading at $75.77.
View which stocks have been most impacted by COVID-19

How often does Novozymes A/S pay dividends? What is the dividend yield for Novozymes A/S?

Novozymes A/S announced a dividend on Monday, March 1st. Shareholders of record on Monday, March 15th will be paid a dividend of $0.8492 per share on Wednesday, March 31st. This represents a dividend yield of 1.38%. The ex-dividend date is Friday, March 12th.
View Novozymes A/S's dividend history

Is Novozymes A/S a good dividend stock?

Novozymes A/S pays an annual dividend of $0.56 per share and currently has a dividend yield of 0.74%. The dividend payout ratio of Novozymes A/S is 36.60%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Novozymes A/S will have a dividend payout ratio of 30.77% next year. This indicates that Novozymes A/S will be able to sustain or increase its dividend.
View Novozymes A/S's dividend history.

Who are Novozymes A/S's key executives?

Novozymes A/S's management team includes the following people:
  • Ms. Ester Baiget, Pres & CEO (Age 50, Pay $2.73M)
  • Mr. Lars Green M.Sc., MSc, Exec. VP & CFO (Age 54, Pay $1.75M)
  • Ms. Graziela Chaluppe dos Santos Malucelli, COO and Exec. VP of Operations, Supply & Quality (Age 48)
  • Mr. Tobias Cornelius Bjorklund, Head of Investor Relations
  • Mr. Tue Micheelsen, VP of Global Sales & Marketing
  • Mr. Morten Enggaard Rasmussen, Exec. VP of People, Sustainability & Brand
  • Mr. Pedro Luiz Fernandes, Head of Corp. Affairs & Sustainability - Novozymes Latin America
  • Mr. Anders Lund, Exec. VP of Consumer Biosolutions (Age 48)
  • Mr. Sebastian Søderberg, VP and Head of New Bus. Devel. - Incubations & Acquisitions
  • Ms. Tina Sejersgard Fano, Exec. VP of Agriculture & Industrial Biosolutions (Age 52)

Who are some of Novozymes A/S's key competitors?

What is Novozymes A/S's stock symbol?

Novozymes A/S trades on the OTCMKTS under the ticker symbol "NVZMY."

How do I buy shares of Novozymes A/S?

Shares of NVZMY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Novozymes A/S's stock price today?

One share of NVZMY stock can currently be purchased for approximately $75.77.

How much money does Novozymes A/S make?

Novozymes A/S has a market capitalization of $17.29 billion and generates $2.15 billion in revenue each year. The biotechnology company earns $432.79 million in net income (profit) each year or $1.53 on an earnings per share basis.

How many employees does Novozymes A/S have?

Novozymes A/S employs 6,185 workers across the globe.

Does Novozymes A/S have any subsidiaries?

The following companies are subsidiares of Novozymes A/S: Allopartis, Beta Renewables S.p.A., Delta Biotechnology, Earth BioSciences, Grundejerforeningen Hallas Park, Grundejerforeningen Smørmosen, Iogen Bio-Products, MagnaBioAnalytics LLC, Microbiogen PTY Ltd., Natural Industries, Novozymes (China) Biotechnology Co. Ltd., Novozymes (China) Investment Co. Ltd., Novozymes (Shenyang) Biologicals Co. Ltd., Novozymes (Thailand) Limited, Novozymes Australia Pty. Ltd., Novozymes Belgium BVBA, Novozymes BioAg A/S, Novozymes BioAg Inc., Novozymes BioAg Limited, Novozymes BioAg Productos Para Agricultura Ltda., Novozymes BioAg S.A., Novozymes Bioindustrial A/S, Novozymes Bioindustrial China A/S, Novozymes Biologicals Inc., Novozymes Biopharma DK A/S, Novozymes Blair Inc., Novozymes Canada Limited, Novozymes Deutschland GmbH, Novozymes Enzim Dis Ticaret Ltd., Novozymes France S.A.S, Novozymes Hong Kong Ltd., Novozymes Inc., Novozymes Italia S.r.l., Novozymes Japan Ltd., Novozymes Korea Limited, Novozymes Latin America Ltda., Novozymes Malaysia Sdn. Bhd., Novozymes Mexicana S.A. de C.V., Novozymes Mexico S.A. de C.V., Novozymes Nederland B.V., Novozymes North America Inc., Novozymes RUS LLC, Novozymes Singapore Pte. Ltd., Novozymes South Africa (Pty) Ltd., Novozymes South Asia Pvt. Ltd., Novozymes Spain S.A., Novozymes Sweden AB, Novozymes Switzerland AG, Novozymes Switzerland Holding AG, Novozymes UK Ltd, Novozymes US Inc., OrganoBalance GmbH, Pacific Vet Group-USA, Philom Bios, PrecisionBiotics Group Limited, Qingdao Huayuan Fine Bio-Products, Suzhou Hongda Enzyme Co. Ltd., Sybron Biochemicals, TJ Technologies, and Turfal Indústria e Comércio de Produtos Agrônomicos e Biológicos.

When was Novozymes A/S founded?

Novozymes A/S was founded in 2000.

What is Novozymes A/S's official website?

The official website for Novozymes A/S is www.novozymes.com.

Where are Novozymes A/S's headquarters?

Novozymes A/S is headquartered at Krogshoejvej 36, Bagsvaerd G7, 2880.

How can I contact Novozymes A/S?

Novozymes A/S's mailing address is Krogshoejvej 36, Bagsvaerd G7, 2880. The biotechnology company can be reached via phone at 45-4446-0000 or via email at [email protected]

This page was last updated on 7/28/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.